Corporate Integrity Agreement and Its Impact on Industry

Time

Wed, Jun 18 7:15AM
W 10

Title

Corporate Integrity Agreement and Its Impact on Industry

Abstract Summary

The study includes an establishment of division to comply with various pharma regulatory acts, enabling through IT / Technologies. This includes but not limited to Sunshine Act, Safe Harbor Act, PhRMA and FDA enforced off label marketing regulations, Sarbans Oxley Act, etc.

Poster Presenter

Abhishek Harde
MBA, MPharm, RAC,